George E. Katibah, Ph.D.
Affiliations: | Microbiology, Molecular Biology and Biochemistry | University of California, Berkeley, Berkeley, CA, United States |
Google:
"George Katibah"Parents
Sign in to add mentor| Kathleen Collins | grad student | 2014 | UC Berkeley | |
| (Cellular Context and Biochemical Basis of RNA Binding by IFIT5.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sivick KE, Desbien AL, Glickman LH, et al. (2019) Magnitude of Therapeutic STING Activation Determines CD8 T Cell-Mediated Anti-tumor Immunity. Cell Reports. 29: 785-789 |
| Luteijn RD, Zaver SA, Gowen BG, et al. (2019) SLC19A1 transports immunoreactive cyclic dinucleotides. Nature. 573: 434-438 |
| Sivick KE, Desbien AL, Glickman LH, et al. (2018) Magnitude of Therapeutic STING Activation Determines CD8 T Cell-Mediated Anti-tumor Immunity. Cell Reports. 25: 3074-3085.e5 |
| Deng W, Lira V, Hudson TE, et al. (2018) Recombinant promotes tumor rejection by CD8 T cell-dependent remodeling of the tumor microenvironment. Proceedings of the National Academy of Sciences of the United States of America |
| Desbien AL, Gauthier KS, Corrales L, et al. (2018) Abstract 631: Intratumoral activation of STING with a synthetic cyclic dinucleotide elicits antitumor CD8 T-cell immunity that effectively combines with checkpoint inhibitors Cancer Research. 78: 631-631 |
| Sivick KE, Surh NH, Desbien AL, et al. (2017) Comment on "The Common R71H-G230A-R293Q Human TMEM173 Is a Null Allele". Journal of Immunology (Baltimore, Md. : 1950). 198: 4183-4185 |
| McWhirter SM, Glickman LH, Desbien T, et al. (2016) Abstract B020: STING activation in the tumor microenvironment using a synthetic human STING-activating cyclic dinucleotide induces potent antitumor immunity Cancer Immunology Research. 4 |
| Glickman LH, Corrales L, Kanne DB, et al. (2016) Abstract SY39-02: Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity Cancer Research. 76 |
| Glickman LH, Kanne DB, Kasibhatla S, et al. (2016) Abstract 1445: STING activation in the tumor microenvironment with a synthetic human STING-activating cyclic dinucleotide leads to potent anti-tumor immunity Cancer Research. 76: 1445-1445 |
| Corrales L, Glickman LH, McWhirter SM, et al. (2015) Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. Cell Reports. 11: 1018-30 |